This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, and other allied healthcare professionals specializing or certified in the areas of gynecology, obstetrics, internal medicine, family or general medicine.
Goals and Objectives
Vulvovaginitis and vulvodynia are conditions which have a negative impact on a woman’s psychosocial and sexual health. Vulvovaginitis presents with nonspecific symptoms of vaginal discharge, itching, irritation and/or odor. Although most women experience at least a single episode of vulvovaginitis, chronic or recurrent symptoms may occur. Vulvodynia, defined as vulvar pain of at least 3 months duration, without clear identifiable cause, affects up to 16% of women. In 2015, a new definition was introduced which added potential associated factors, which helps in differentiation and treatment of this multifactorial disorder. This activity will review the most common etiologies of vulvovaginitis, focusing on proper evaluation and therapeutic strategies for chronic and recurrent disease. Additionally, the new definition of vulvodynia and a clear diagnostic approach and treatment plan for this chronic pain disorder will be reviewed. At the conclusion of this activity, participants should be able to:
- Evaluate a woman with vulvovaginal symptoms, considering the basic components of pH, microscopic evaluation and appropriate laboratory testing;
- Institute therapeutic and suppressive treatments for chronic or recurrent vulvovaginal symptoms;
- Recognize the complexity of vulvodynia and initiate a multi-disciplinary treatment plan.
CME Release Date: August 2, 2019
Valid for credit through: August 2, 2020
Course type: Video lecture
Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Southern Medical Association designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST complete the activity and the evaluation form. For ABIM MOC points, your information will be shared with the ABIM through the ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.25 hours of Category I credit for completing this activity.
AANPCP: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. All healthcare professionals who are not MDs or DOs will receive a certificate of participation.
Instructions for Participation and Credit
To successfully earn credit, participants must complete the activity online during the valid credit period noted, following these steps:
- Read the goals and objectives, accreditation information, and author disclosures.
- View the educational video of the lecture.
- Study the educational references.
- Online, choose the best answer to each test question. Learners must receive a passing score of 80%.
- Complete the activity evaluation and outcomes.
Upon successful completion of the test, evaluation and attestation, your certificate will be processed and emailed from firstname.lastname@example.org within approximately 1 hour. Credits will be archived for 6 years; at any point within this time period you may login to your account to print a duplicate copy of your certificate.
Click the Disclosure Tab above for Faculty Information
Disclosure of Relevant Financial Relationships
As an organization accredited by the ACCME, Southern Medical Association requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest.
Southern Medical Association encourages Speakers/Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Nancy Phillips, MD
Dr. Phillips is a board-certified obstetrician/gynecologist, Clinical Associate Professor in the Department of Obstetrics, Gynecology & Reproductive Science at Rutgers-Robert Wood Johnson Medical School in New Brunswick, NJ. Her clinical interest is in vulvovaginal health, with an emphasis on vulvodynia. Other areas of interest include menopause and hormone therapy and pelvic pain. She has authored and co-authored many peer-reviewed articles and book chapters in this field, including an on-line Prologue teaching review on vulvovaginal atrophy for the American College of Obstetricians and Gynecologists. Dr. Phillips is also involved in clinical research in areas of vulvodynia, vulvovaginal atrophy and the vaginal microbiome.
- Phillips has disclosed that she is on the Advisory Board of Amgen Pharmaceuticals.
- This activity contains information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries.
Planning Committee/Content Reviewer(s)/SMA Staff:
The following planning committee members have no relevant financial relationships to disclose:
Veronica K. Piziak, MD
Donald DiPette, MD
Susan Peck, MSN, APN
Lee Boughton, MA, SMA Staff
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase purchase access to this course.